SCHEMBL21630440

SCHEMBL21630440

Nc1cccnc1-c1cccc2c1oc1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.46
LIMK1 P53667 1/20 0.42
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.41
HPGD P15428 3/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CDK2 P24941 1/20 0.40
PRKDC P78527 4/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CB P42338 1/20 0.39
DRD4 P21917 1/20 0.39
ADK P55263 1/20 0.38
NPC1 O15118 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RAB9A P51151 2/20 0.37
NQO1 P15559 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17727864 0.80 ALOX5 (0.57) ALOX5LIMK1KDM4EALDH1A1MAPT
SCHEMBL29395390 0.79 KDM4E (0.48) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL19094354 0.79 KDM4E (0.48) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL23630885 0.77 ALOX5 (0.47) ALOX5LIMK1KDM4EALDH1A1MAPT
SCHEMBL16405884 0.77 ALOX5 (0.56) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL26478452 0.77 BCHE (0.51) ALOX5KDM4EMAPTCDK2MEN1
SCHEMBL21630439 0.76 POLB (0.48) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL2342912 0.76 ALDH1A1 (0.48) ALOX5LIMK1KDM4EALDH1A1MAPT
SCHEMBL10945864 0.76 ALOX5 (0.68) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL28312221 0.76 ALDH1A1 (0.50) KDM4EALDH1A1MAPTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112194670-A Organic compound and organic electroluminescent device using same 上海大学 2021-01-08 CN disclosed
CN-110776515-A Compound having azaindeno [1, 2, c ] phenanthrene ring structure and organic electroluminescent element using same 保土谷化学工业株式会社 2020-02-11 CN disclosed
US-20200035927-A1 COMPOUND HAVING AZAINDENO[1,2-c]PHENANTHRENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME HODOGAYA CHEMICAL CO., LTD. (JP) 2020-01-30 US disclosed
US-20200035927-A1 COMPOUND HAVING AZAINDENO[1,2-c]PHENANTHRENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME HODOGAYA CHEMICAL CO., LTD. (JP) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200035927-A1 COMPOUND HAVING AZAINDENO[1,2-c]PHENANTHRENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME AZI2, DNMT1, TET1 ALOX5 2037/4885LIMK1 2868/4885KDM4E 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.